Graphical top of the content well

Health Encyclopedia

Search health encyclopedia

Go

Medullary carcinoma of thyroid

Definition

Medullary carcinoma of the thyroid is cancer of the thyroid gland that starts in cells that release a hormone called calcitonin. Such cells are called "C" cells.

Alternative Names

Thyroid - medullary carcinoma; Cancer - thyroid (medullary carcinoma); MTC

Causes, incidence, and risk factors

The cause is unknown. Unlike other types of thyroid cancer, medullary carcinoma of the thyroid (MTC) is believed to be related to radiation therapy (a type of cancer treatment).

There are two forms of MTC:

  • Sporadic MTC does not run in families. The majority of MTCs are sporadic. This form mainly affects older adults.
  • Inherited MTC runs in families.

You have an increased risk of medullary carcinoma of the thyroid if you have:

Other types of thyroid cancer include:

Symptoms

Signs and tests

The health care provider will perform a physical exam. Lymph nodes in the neck may be swollen. Thyroid function tests are usually normal. However, an examination of the thyroid may reveal single or multiple nodules.

Other tests that may be used to diagnose medullary carcinoma of the thyroid include:

Treatment

Treatment involves surgery to remove the thyroid gland and surrounding lymph nodes. Chemotherapy and radiation do not work very well for this type of cancer.

Support Groups

For additional information, see cancer support groups.

Expectations (prognosis)

Approximately 86% of those with medullary carcinoma of the thyroid live at least 5 years after diagnosis. The 10-year survival rate is 65%.

Complications

Complications may include:

  • Cancer spreads to other areas of the body
  • Parathyroid glands are accidentally removed during surgery

Calling your health care provider

Call your health care provider if symptoms of medullary carcinoma of the thyroid develop.

Prevention

Prevention may not be possible. However, being aware of your risk factors, especially your family history, may allow for early diagnosis and treatment.

Review Date:10/31/2006
Reviewed By:Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.

Florida Health Finder - Health Outcome Data
No data available for this condition/procedure.
Florida Health Finder - Health Encyclopedia
Images
More Features
end of graphical look of the webpage